by John Conrad | Nov 20, 2025 | Member News
It was exciting to see Dimension Bio featured in Fast Company this week — a national spotlight that underscores just how far this Chicago-born biotech has pushed the boundaries of regenerative medicine. The profile traces the company’s journey from its early work in...
by John Conrad | Nov 20, 2025 | Member News
Abbott confirmed a $21 billion deal to acquire Exact Sciences, instantly becoming one of the biggest moves in diagnostics in years. Abbott will pay $105 per share in cash, a 51% premium, sending Exact’s stock sharply higher for a second straight day. The deal gives...
by John Conrad | Aug 1, 2025 | Member News, NewsBrief
Chicago biotech startup ClostraBio has secured GRAS (Generally Recognized as Safe) status for its flagship probiotic ingredient CLB101™, clearing the path for the first commercially available strain of Anaerostipes caccae in the U.S. What Makes It Different Unlike...
by John Conrad | Jan 8, 2025 | Grants, NewsBrief
In partnership with G2G Consulting, we are please to provide the January 2025 Grants report, showcasing 196 non-dilutive government funding opportunities across diverse biomedical and life sciences sectors. The comprehensive report underscores significant funding...
by John Conrad | Dec 19, 2024 | Member News
Chicago-based Xentria advances Illinois’ position in life sciences innovation through strategic academic partnership* Illinois’ biotechnology sector continues to demonstrate its growing prominence with Xentria, Inc., a Chicago-based clinical-stage...
by John Conrad | Dec 18, 2024 | Capital Pulse
Flow Medical, a startup spun out of UChicago Medicine, has secured $5 million in seed funding, with UCM Ventures making its inaugural investment in the company. The startup, founded by three University of Chicago faculty members, is developing a specialized catheter...
